Related Experiment Video

Updated: May 24, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

Biomarkers

Viorel G Florea1, Inder S Anand

  • 1Department of Medicine, University of Minnesota Medical School, 420 Delaware Street Southeast, Minneapolis, MN 55455, USA. flore022@umn.edu

Heart Failure Clinics
|March 13, 2012
PubMed

Insights

Research identifies conditions leading to heart failure and asymptomatic left ventricular dysfunction. While natriuretic peptides and troponin are used for advanced heart failure, other biomarkers offer insights for future therapies.

Area of Science:

  • Cardiology
  • Biochemistry
  • Epidemiology

Background:

  • Heart failure is preceded by asymptomatic left ventricular remodeling and dysfunction (stage B heart failure).
  • Various biochemical markers are associated with cardiac remodeling and dysfunction.
  • Current biomarkers like natriuretic peptides and cardiac troponin aid in managing advanced heart failure (stages C and D).

Purpose of the Study:

  • To review antecedent conditions predisposing individuals to heart failure.
  • To discuss biochemical markers characterizing left ventricular remodeling and dysfunction.
  • To explore the potential of novel biomarkers in understanding pathophysiology and developing new therapies.

Main Methods:

  • Review of epidemiologic, clinical, and basic research.
  • Analysis of described biochemical markers.
  • Discussion of current biomarker applications and future research directions.

Main Results:

  • Several conditions predispose individuals to stage B heart failure.
  • Numerous biochemical markers are linked to cardiac remodeling and dysfunction.
  • Beyond natriuretic peptides and troponin, other biomarkers offer insights into left ventricular dysfunction.

Conclusions:

  • Understanding early stages of heart failure is crucial.
  • Biomarkers beyond current clinical use hold potential for research and therapeutic development.
  • Further investigation into novel biomarkers may reveal new treatment strategies for heart failure.

More Related Videos

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Microbial Biosensors01:17

Microbial Biosensors

Microbial biosensors are analytical devices that utilize living microbes to detect specific substances through measurable signals. These devices consist of two main components: biosensing organisms and signal-transducing elements. Biosensing organisms, such as Escherichia coli or Saccharomyces cerevisiae, are typically housed in multiwell plates connected to transducers, enabling rapid, real-time detection of target analytes.Signal Generation MechanismWhen a target analyte—such as...